Analysts Say U.S. MSOs Trulieve and Curaleaf Are a Buy With Upside of Up to 177% North of the Border, Cannabis 2.0 Sales Could Lift Shares of Valens and VIVO... read more →
According to Analysts, Better Than Expected Earnings Make These 3 Top U.S. Multi-State Operators a Buy Trulieve and Green Thumb Beat Wall Street Estimates After Announcing Q3 Earnings Earlier This... read more →
MKM Partners Issues Mixed Ratings & Price Targets on 8 Canadian and U.S. Pot Stocks U.S. based analyst Bill Kirk of MKM Partners initiated coverage on eight marijuana stocks this... read more →
Three of the Leading Multi-State Operators Received Outperform Ratings and Bullish Price Targets One of Wall Street's most respected cannabis analysts initiated coverage on five U.S. multi-state operators (MSO) today.... read more →
Curaleaf’s Misfortune Leads to a Potential Buying Opportunity for Investors Curaleaf Holdings (CSE: CURA) (OTCQX: CURLF) officially responded to the U.S. Food and Drug Administration's (FDA) warning letter which the... read more →
